You read the warnings, hear the debates, and suddenly even familiar choices feel uncertain.
For many expectant parents, decisions about everyday medication can quickly become a source of concern.
According to MedPage Today, reporting on research published in JAMA Pediatrics by Kira Philipsen Prahm and colleagues at Copenhagen University Hospital Rigshospitalet, one of the most discussed questions has now been examined using extensive Danish data.
A long-running debate
The safety of acetaminophen during pregnancy has been widely debated in recent years. Concerns have circulated about a possible link to developmental conditions, including autism.
Also read: This happens to your body if you eat blackberries every day
To investigate this, researchers analyzed nationwide data covering more than 1.5 million children born in Denmark over a 25-year period.
What the findings show
The results were consistent across multiple approaches. No meaningful association was found between prenatal exposure to acetaminophen and autism in children.
This held true regardless of how exposure was assessed:
- Timing during pregnancy
- Dosage levels
- Comparisons between siblings
These findings suggest that earlier concerns may have been influenced by other underlying factors rather than the medication itself.
Also read: Hidden bone disease affects 40 percent of adults worldwide – are you one of them?
A consistent picture
Similar studies conducted in other countries have reached comparable conclusions, strengthening the overall evidence base.
Researchers emphasize that when results are repeated across large populations and different methods, confidence in the findings increases.
Overall, the study indicates that this commonly used medication does not appear to raise the risk of autism when used during pregnancy.
Also read: Study: New migraine treatments could cut monthly attacks